Author:
Tekçe Ertuğrul,Etiz Durmuş
Publisher
Springer International Publishing
Reference84 articles.
1. National Comprehensive Cancer Network. (2020) NCCN clinical practice guidelines in oncology: Non-Small Cell Lung Cancer. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed 20 June 2020 2020.
2. Torok JA, Clarke JMTB, Salama JK. Non–small cell lung cancer. In: Tepper JE, Foote RL, Michalski JM, editors. Gunderson & Tepper’s clinical radiation oncology. 5th ed. Philadelphia: Elsevier; 2021. p. 836–67.
3. Schneider BJ, Daly ME, Kennedy EB, Stiles BM. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: American Society of Clinical Oncology endorsement of the American Society for Radiation Oncology evidence-based guideline summary. J Oncol Pract. 2018;14(3):180–6. https://doi.org/10.1200/JOP.2017.028894.
4. Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JA, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol. 2009;27(20):3290–6.
5. Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys. 2011;81(5):1352–8.